Sphingolipids and their metabolites are implicated in signal transduction, but the mechanisms are still poorly understood. In particular, the presumed function of ceramide as a second messenger remains controversial. Here, we emphasize the importance of both ceramide and sphingomyelin for membrane structure. T h e effects of sphingolipid turnover in the induction and effector phases of apoptosis are explained by their impact on membrane microdomains that are relevant for cell signalling or changes in morphology. T h e topology of sphingolipid metabolism is important because of their limited transbilayer and intermembrane movement. For instance, glycosylceramide synthase converts de noeo synthesized ceramide to glycosylceramide, but it is neither a general attenuator of ceramide accumulation at the plasma membrane, nor of the apoptotic process. Synthetic alkyl-lysophospholipids modulate membrane-lipid composition and, therefore, apoptosis sensi t ivi t y .
. T h e knowledge that synthetic, short-chain Cer can induce apoptosis has led to the oversimplified extrapolation that Cer formation is an obligatory step in the apoptotic process. T h e main reason why this issue is still controversial [3-61 is because the molecular basis of Cer production is in many cases unresolved. It is, therefore, often not possible to abrogate Cer formation by genetic means and to examine the consequences for apoptosis induction. Several possible intracellular target molecules for Cer have been proposed, such as the protein phosphatases, PP1 and PP2A, and the protein kinases, protein kinase Ci, kinase suppressor of Ras (KSR) and 7] . but these have not been verified by follow-up studies. Thus, unlike diacylglycerol and some of the phosphoinositides, Cer has not been convincingly validated as lipid second messenger. Although Cer and diacylglycerol have a similar structure, which has been suggestive for a similar binding to cysteine-rich C1 domains of protein kinases [7] , their occurrence, location and structural behaviour in membranes is quite different [S] (see below), which could well explain some of the controversies in the field.
Part of the confusion in the literature on the significance of Cer formation also stems from the fact that there are at least two phases of Cer formation. Some investigators are able to detect rapid, transient elevation of Cer levels, minutes after the delivery of an apoptotic stimulus, while, in addition, slow and sustained Cer formation is generally observed in the effector phase of apoptosis, i.e. secondary to caspase activation [4,8-lo].
As we will discuss, the cause and consequences of these two responses are completely distinct.
Ceramide as determinant of membrane structure: the induction phase
Through intermolecular hydrogen bonding and its two long, saturated hydrophobic chains, Cer fits better than diacylglycerol in a lipid bilayer structure, and thereby segregates preferentially into lateral microdomains (rafts/caveolae) where it is packed tightly in homodimers/multimers, as well as with cholesterol and the other sphingolipids (see [5,11-141 and references therein). In fact, substantial amounts of Cer can be measured in isolated rafts/caveolae, even from unstimulated cells [13,14]. For the same physico-chemical reason, natural Cer (not short-chain Cer) does not transfer spontaneously between lipid bilayers, and it is unlikely to 'flip-flop' as readily as diacylglycerol. It might, therefore, be restricted to the side of the bilayer on which it is generated [5,15]. Thus, if it is generated from the major pool of sphingomyelin (SM) in the exoplasmic side of membrane rafts (or rather at the luminal side of recycling endosomes; see below), Cer is unlikely to act as a rapidly generated second messenger for a cytoplasmic target protein at the opposite side of the membrane T h e CD95-induced, aSMase-mediated Cer production is a rapid event (occurring within seconds) and occurs locally (in rafts). If basal Cer levels in these rafts are too high (which may easily be the case [13,14]), stimulated rapid Cer production may escape detection and may also no longer be effective in facilitating CD95 clustering and apoptosis induction. As a cautionary note, aSMase-'-mice develop a Niemann-Pick-type disease and their cells have many abnormalities [6,21]. These include altered T-cell receptor responses, a severely altered composition of sphingolipids and cholesterol in their membranes, and a defect in the formation of functional lipid rafts, which can no longer be isolated by the standard procedures based on detergent insolubility [21].
One can imagine that general alterations in lipid composition rather than defective Cer formation may determine apoptosis sensitivity in such cells. We and others [20] have found that aSMase deficiency or overexpression did not affect CD95-, radiation-or cancer drug-induced apoptosis in B-lymphoblastoid cells. Clearly, aSMase activity is, in general, not essential for the induction of apoptosis, but it seems to facilitate this process in some cases.
Sphingomyelin as determinant of membrane structure: the effector phase T h e deficiency in aSMase did not affect the slow and sustained Cer formation that is generally observed in cells undergoing apoptosis [ 191. We concluded that this Cer, produced downstream from inducer caspase activation in Jurkat T cells stimulated via CD95 or by y-radiation or etoposide, results from S M hydrolysis by an undefined nSMase activity [23, 24] . T h e function of nSMase(s) in apoptosis is difficult to assess, mainly because the enzyme, which acts in the plasma membrane and which probably also localizes in rafts/caveolae [ 141, has not been cloned. T h e function of the isozyme that has been cloned, nSMasel [25] , is unknown [6] . It localizes in the endoplasmic reticulum and/or nucleus, and we and others found that its expression/overexpression in cells does not affect Cer formation during apoptosis or apoptosis itself (see [6, 26] , and references therein).
We addressed the mechanism of the slow Cer formation further and found that, during apoptosis, scrambling of membrane phospholipids (loss of bilayer asymmetry), with phosphatidylserine exposure at the cell surface, leads to transbilayer movement and consequent hydrolysis of S M at the cytoplasmic side of the plasma membrane [24] . Scrambling and loss of S M has profound effects on the physico-chemical properties, e.g. cholesterol content and fluidity [24, 27] , of the plasma membrane (microdomains), which facilitates membrane blebbing, vesicle shedding and apoptotic body formation. Replenishment of SM to the apoptotic cell prevented these surface changes. Thus, the breakdown of SM, rather than the production of Cer, seems to be the determining factor for these morphological changes in the apoptotic cell [24] (Figure 1) .
While Cer is formed, in the effector phase of apoptosis, at the cytoplasmic side of the plasma membrane from the bulk S M that was initially located in the outer leaflet [24] , there is also evidence for a stimulus-induced [e.g. by tumour necrosis factor a (TNFa) or vitamin D3] nSMase activity acting on the minor SM pool (10-20 ",) in the inner leaflet of the plasma membrane [28, 29] . Whether this pool topologically corresponds to rafts/caveolae, and whether the conversion of S M into Cer at these sites (at 15-60 min) is relevant for apoptosis and may have a signalling or a membrane structural function, remains to be seen.
Topology of ceramide formation: an important variable
In an attempt to modulate Cer accumulation by boosting its glycosylation, we overexpressed glucosylceramide synthase (GCS) retrovirally in Jurkat cells [30] . Such an approach was previously undertaken b y Cabot and co-workers [31, 32] , and appeared to be effective in the attenuation of the Cer response of MCF-7 cells to various chemotherapeutic drugs as well as T N F a . Moreover, it protected cells against the cytotoxicity of these stimuli. We found that stable G C S overexpression in Jurkat cells caused a 10-fold increase in GCS activity in zritro and a 7-fold elevated basal glucosylceramide level in oivo, as expected. However, Cer that accumulated during apoptosis induced via CD95 or by exposure to etoposide, ;.-radiation or bacterial SMase, was not glycosylated by GCS, nor was apoptosis itself affected [30] . Similar results were obtained in GM95 melanoma cells stably transfected with functional GCS, and
Mechanism of Cer formation during the execution phase of apoptosis
An apoptotic stimulus induces phospholipid scrambling, i.e. loss of lipid asymmetry. in the plasma membrane, Phosphatidylserine (PS) becomes exposed at the cell surface and SM appears in the inner leaflet where it is immediately hydrolyzed to Cer by an nSMase. SM hydrolysis leads t o redistribution of cholesterol (Chol) from the plasma membrane towards the cell interior or an extracellular acceptor (lipoprotein). Reduced SM and Chol allows membrane blebbing and vesicle shedding. PE. 
-

exposed to various drugs (Veldman and Levade, submitted for publication). Therefore, G C S located in the Golgi is topologically segregated from Cer produced from S M in the plasma membrane. In contrast, de noeo synthesized Cer, as well as an exogenously supplied cell-permeable C2-Cer analogue (inducing apoptosis), were efficiently glycosylated [30] , apparently owing to different Cer topology and different physico-chemical behaviour of the short-chain Cer species, respectively. This is just one illustration that exogenous Cer analogues often do not mimic the behaviour of endogenously produced Cer, and one should be cautious to use it as a tool in a cell biological setting (e.g. as argument that Cer would be a second messenger) [5, 23] . I t is clear from these findings that only de no00 synthesized Cer molecules (and cell-permeable Cer analogues) have access to GCS, and that Cer formed in the plasma membrane does not spontaneously transfer to other, intracellular membranes (as noted already above [5, 15] ). Thus, if the de novo pathway is responsible for Cer generation in the MCF-7 cells used by Cabot and co-workers [33] , this may well explain why G C S expression attenuates Cer in that system but not in Jurkat and GM95 cells. That G C S protects against apoptosis induction in the MCF-7 cells is more difficult to explain. Since effects on lipid levels and viability in this cell system were only seen after a very long time (days) of exposure to the cytotoxic drug, adriamycin, or to T N F a [31, 32] , they may have been secondary to general alterations in cellular lipid homeostasis. In any case, we note here that although G C S expression and activity may somehow protect certain cancer cells (e.g. breast) from apoptosis, this may not be the case in other cell types [30] .
Alkyl-lysophospholipids as modulators of signal transduction and membrane lipid turnoverkomposition, and as inducers of apoptosis
Since SM in the plasma membrane is important for its physico-chemical properties, microdomain formation, and blebbing and vesiculation during apoptosis, we sought to modulate membrane lipid composition by interfering with phospholipid biosynthesis and to look for effects on apoptosis induction. For this, we used the synthetic alkyllysophospholipid, 1 -0-octadecyl-2-0-methylglycero-3-phosphocholine (ALP; Et-18-OCH3; Edelfosine), an anticancer agent that induces apoptosis in a variety of tumour cells [34-371. ALP incorporates easily into cell membranes [38] with pleiotropic effects on signal transduction. ALP interferes with phospholipid metabolism and with subsequent formation of lipid second messengers that act in mitogenic and cell survival pathways [36] . It inhibits the anti-apoptotic mitogen-activated protein kinase/extracellular-signalregulated protein kinase and phosphoinositide 3-kinase/protein kinase B (PKB) pathways, and stimulates the pro-apoptotic stress-activated protein kinase/c-Jun N-terminal kinase pathway Perhaps the most important physiological target of ALP is C T P :cholinephosphate cytidylyltransferase [39], the enzyme that converts phosphocholine into CDP-choline in the endoplasmic reticulum, being the rate-limiting step in phosphatidylcholine (PC) biosynthesis. Using a mouse T-lymphoma cell line, S49, we found that ALP strongly inhibits PC synthesis and that the ensuing apoptosis can be prevented by providing the cells with an alternative pathway with which to synthesize PC, that is the acylation of exogenously supplied IysoPC (Figure 2) 
Do sphingolipids in rafts determine sensitivity of cells to stress-induced apoptosis?
An ALP-resistant variant cell, S49A'', no longer undergoes ALP-induced apoptosis and, in addition, appeared to be cross-resistant to various other stress agents/treatments [41]. These cells no longer internalized (endocytosed) ALP (3H-labelled ET-18-OCH:J. Interestingly, PC synthesis in these cell was normal (also in the presence of ALP), but synthesis of SM was blocked (Figure 3) . This must have consequences for the physico-chemical properties of the plasma membrane [27], particularly lipid raft formation. Could defective SM synthesis and raft assembly prevent ALP internalization and confer resistance to apoptosis ? Indeed, artificial disruption of lipid rafts in S49 cells, e.g. by cholesterol depletion with /?-cyclodextrin [42], inhibited ALP uptake and the induction of apoptosis (data not shown). We hypothesize that intact membrane rafts are 'sensors' for ALP and perhaps other stress agents that need membrane endocytosis to be effective, and that cells can escape from these toxic agents by shutting off their endocytosis through a block in SM synthesis and functional raft formation.
Concluding remarks
We have emphasized here the membrane structural and topological significance of Cer and SM in the induction and execution phases of apoptosis. For that matter, the glycosphingolipids may possibly have a similar significance. A second messenger function for Cer in the classical sense, like for diacylglycerol, remains possible [7] but more rigorous proof is needed. It should be realized that, if Cer is tightly packed in a membrane microdomain (raft/caveolus), and given its very small polar headgroup, its interaction with a 
